The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need for precise ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive growth following a drop in Covid-test ... climb is a positive for the ...

Follow today’s news live. Re-election of Trump would be good for Australia: Hockey 22:45 Hockey says a ...

Experts explain how the Qantas saga is impacting the minds of voters and why Prime Minister Anthony Albanese is held "to a ...

Experts explain how the Qantas saga is impacting the minds of voters and why Prime Minister Anthony Albanese is held "to a ...

Despite the increase in in-person early voting turnout, mail-in ballots are down this year. Numbers Tarrant County reported to the Texas Secretary of State show it receiving a total of 19,469 ballots ...

The growing prevalence of cardiovascular and thrombotic disorders is driving strong demand for D-dimer testing. As blood clot-related risk factors continue to increase, the need f ...

It also releases a dose of the immunosuppressant everolimus, similar to Abbott’s metal drug-laden stents. R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below ...

"The positive results at two years reinforce Esprit BTK's potential to revolutionize the treatment of peripheral artery disease below the knee," said Jennifer Jones-McMeans, divisional vice president ...

*Abbott completed the acquisition of CSI on April 27, 2023. For purposes of calculating organic sales growth, the impact from this acquired business has been excluded from January through April 2024.